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ABSTRACT 
 
Barakol (10 mg/kg, i.p.), an active ingredient extracted from Cassia siamea, has been shown to have
anxiolytic properties on the elevated plus-maze at a low dose similar to diazepam and to increase exploratory and
locomotor behaviour. Drugs increasing serotonergic function also alter exploratory activity. The mechanism
underlying the effects of barakol on exploratory behaviour has not been studied, therefore, the aim of the present
study was to investigate exploratory activity in rats treated with barakol compared with drugs known to have
specific action on the 5HT system. Exploratory behaviours were monitored in the rat using the holeboard model.
The results show that the 5HT1A receptor agonist 8-OH-DPAT (1 mg/kg, i.p.) significantly (P<0.05) decreased
exploratory behaviours including rearing, number of head dips and time spent head dipping and the effects were
antagonised by the selective 5HT1A receptor antagonist WAY 100635 (1 mg/kg, s.c.). Paroxetine (20 mg/kg, i.p.)
also significantly (P<0.05) reduced all exploratory activity and grooming. In contrast, barakol (10 mg/kg, i.p.) and
diazepam (1 mg/kg, i.p.) had no effect on exploration. In conclusion, a low dose of barakol has no effect on
exploratory behaviours using the holeboard test indicating that 5HT mechanism and 5HT1A receptor may not
involved in the anxiolytic effects of barakol. 
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INTRODUCTION   
 Barakol is an active ingredient extracted 
from Cassia siamea Lam. of the family 
Caesalpiniaceae, a plant used in Thai traditional 
medicine. Barakol has both the behavioural effects 
and neurochemical actions1-3. On the elevated plus 
maze, barakol has been shown to produce both an 
anxiolytic effect in rats similar to diazepam but also 
to increase exploratory and locomotor behaviour1. 
However, later studies have shown no anxiolytic 
effect of barakol in rats or mice either on the plus-
maze or using the shock-probe burying test3,4. 
Administration of barakol to mice which has been 
reported to reduce spontaneous locomotor activity, 
increase the number of sleeping animals and 
prolong the sleeping time induced by thiopental, 
suggesting a sedative effect.3, 5, 6 The possible 
mechanisms underlying the effects of barakol on 
the central nervous system have focused on the 
dopaminergic system2,3. Barakol reduced K+-
stimulated release of endogenous dopamine from 
rat striatal slices in a manner similar to dopamine 
receptor agonists and this effect was inhibited by a 
D2 receptor antagonist2. Furthermore, barakol has 
been shown to inhibit both the hyperlocomotor 
activity and the increases in striatal dopamine 
release and dopamine turnover induced by 
methamphetamine, indicating an inhibitory effect 
on the dopaminergic system3.  
The effect of barakol on the serotonergic 
system has not been extensively studied. Barakol 
has been shown to suppress 5-hydroxytryptophan-
induced head shakes in rats, suggesting a 5HT2 
antagonist action of barakol7. In a preliminary study 
by Thongsaard and colleagues2 barakol increased 
K+-stimulated endogenous 5HT release from rat 
hippocampal slices. There is some evidence for the 
involvement of the serotonergic system in 
exploratory behaviour8,9. For example, the 5HT1A 
receptor agonists, flesinoxan and 8-hydroxy-2-(di-
n-propylamine) tetralin (8-OH-DPAT), but not 
benzodiazepines dose-dependently decreased all 
exploratory behaviours in mice8 while N-{2-[4-(2-
methoxyphenyl)-1-piperazinyl] ethyl} -N-(2-pyridinyl) 
cyclohexane-carboxamide trihydrochloride (WAY 
100635), the selective 5HT1A receptor antagonist 
significantly increased the frequency of exploration 
and reduced fear-induced avoidance of the figure-
eight maze9. In mice naïve to the maze, infusions of 
WAY-100635 into the median raphe nuclei 
increased open arm exploration10. Therefore, the 
effect of barakol in the rat on exploratory behaviour 
remains debatable. As does the possibility that the 
mechanism by which barakol might alter 
exploration could involve serotonergic function. 
 The aim of the present study was to 
compare the effect of barakol administrated acutely 
on exploratory behaviour using a holeboard test, an 
animal model of exploration with the effects of 
drugs that alter 5HT1A mediated serotonergic 
function. 
 
MATERIALS AND METHODS  
Animals  
Male Wistar rats weighing 200 - 250 g 
(The National Laboratory Animal Centre, Mahidol 
University, Thailand) were used. The rats were 
housed in groups of four in a room with a light/dark 
12:12 cycle (0700 - 1900 light on) and maintained 
at a temperature of 22 + 0.5 °C. Laboratory pellets 
(National Laboratory Animal Center, Thailand) and 
water were available ad libitum.  The rats were 
inexperienced to the holeboard apparatus. 
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Chemicals  
Barakol was extracted and identified by 
the method described in Thongsaard and 
colleagues, 200111. Briefly, a C. siamea plant was 
harvested from the Ratchaburi Province, Thailand 
between July-August.  The fresh young leaves and 
flowers were cut into small pieces and boiled in 
0.5% sulfuric acid for 30 min.  The mixture was 
blended and filtered. Then, the filtrate was 
alkalinized with concentrated sodium bicarbonate 
and subsequently extracted with chloroform.  The 
chloroform extract was filtered, mixed with 5% 
acetic acid and neutralized with 25% ammonium 
hydroxide to get greenish crystals, crude barakol 
extract with 0.3% yield.  Finally, concentrated 
hydrochloric acid was added to obtain barakol 
hydrochloride and the mixture was dried by vacuum 
filtration to form yellowish crystals, anhydrous 
barakol hydrochloride. The identity of the 
compound was checked by thin layer 
chromatography and nuclear magnetic resonance. 
Barakol was freshly dissolved in 0.9% saline before 
injection.  
Diazepam (DZP)(10 mg/2 ml ampoule), 
purchased from Roche (Welwyn Garden City, UK), 
was diluted with 0.9% saline to 1 mg/kg before use. 
Paroxetine (Glaxo Smith Kine, Middlesex, UK) was 
dissolved in distilled water (20 mg/2 ml distilled 
water). 8-OH-DPAT and WAY 100635, obtained 
from the Department of Medicinal Chemistry, 
Wyeth Research, UK) were dissolved in 0.9% 
saline. 
 
 
The holeboard apparatus 
The holeboard apparatus, raised to a 
height of 7 cm above floor level, was made of wood 
covered with dark Formica (62 x 62 x 36 cm) with 
sixteen holes, each 4 cm in diameter, equally spaced 
in the floor. The apparatus was cleaned between 
rats by wiping the walls and the floor with 20% 
ethanol. The behaviours were recorded by video 
camera hanging from the ceiling above the center of 
the apparatus. The number of rears, head dips, 
grooming and the time spent head dipping were 
manually scored by two observers from the video 
tapes. A dip was considered to take place when the 
head was introduced into the holes at least to the 
level of the eyes. 
 
Experiment procedures 
All experiments were performed in a quiet 
room between 8.00 - 12.00 am under low-intensity 
natural light.  The procedures used for the 
holeboard were modified from that described by 
File & Wardill (1975)12. Rats were transferred to 
the behavioural observation room about 30 min 
prior to the experiment. Barakol (10 mg/kg, i.p.) 
was administered 30 min before exposure to the 
holeboard either in the presence of vehicle (0.9% 
saline), paroxetine (20 mg/kg, i.p.), 8-OH-DPAT 
(0.5 mg/kg, s.c.) or diazepam (1 mg/kg, i.p.). In one 
study the 5HT1A receptor antagonist WAY 100635 
(1 mg/kg, s.c.) was given 30 min before 8-OH-
DPAT to determine whether the effects of  8-OH-
DPAT on exploratory behaviors were mediated via 
5HT1A receptor. For the test, rats were placed 
individually in the centre of the floor of the box and 
their exploratory behavior examined throughout the 
10 min exposure to the holeboard. At the end of the 
experiment, the animal was returned to its home 
cage. 
The experimental protocol was approved 
by the Animal Ethics Committee of Srinakharinwirot 
University for the use of animal subjects and the 
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procedures are in compliance with the International 
Guiding Principles for Biomedical Research 
Involving Animals provided by the National 
Research Council of Thailand. 
 
Statistical analyses  
All data are expressed as mean + SEM. 
The results were analysed using One-way analysis 
of variance (ANOVA) followed by post hoc 
Duncan’s test. Differences were considered 
statistically significant when P<0.05. 
 
 
 
 
 
 
 
 
 
RESULTS  
Rearing behaviour  
Both 8-OH-DPAT (0.5 mg/kg, s.c.) and 
paroxetine (20 mg/kg, i.p.) significantly (p<0.05) 
lowered the number of rears per minute compared 
to controls. Prior administration of WAY-100635 (1 
mg/kg, s.c.) significantly (p<0.05) reversed the 8-
OH-DPAT-induced decrease in rearing. Neither 
DZP (1 mg/kg, i.p.) nor barakol (10 mg/kg, i.p.) had 
any significant effect on rearing (Fig. 1). 
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Fig. 1. Effects of barakol (10 mg/kg, i.p.), diazepam (DZP; 1 mg/kg, i.p.), 8-OH-DPAT (DPAT; 0.5 mg/kg, s.c.), 8-OH-
DPAT (0.5 mg/kg, s.c.) + WAY-100635 (WAY; 1 mg/kg, s.c.)  and paroxetine (20 mg/kg, i.p.) compared to controls
(CONT; 0.9% saline either i.p. or s.c.) on number of rear per minute during a 10 min exposure to the holeboard test.
Data are expressed as mean + SEM of the number of rearing per minute. * P< 0.05 compared to subcutaneous injection,
# P< 0.05 compared to 8-OH-DPAT injection alone, @ P< 0.05 compared to controls (i.p.) (n = 10 rats/treatment
group) (one way ANOVA with post hoc Duncan’s test). 
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Number of head dips 
8-OH-DPAT (0.5 mg/kg, s.c.) alone 
significantly (p<0.05) decreased the number of head 
dips while administration of WAY-100635                      
(1 mg/kg, s.c.) prior to 8-OH-DPAT fully reversed 
the effects of 8-OH-DPAT. Paroxetine (20 mg/kg, 
i.p.) also significantly (p<0.05) decreased the 
number of head dips while DZP (1 mg/kg, i.p.) and 
barakol (10 mg/kg, i.p.) had no significant effects 
(Fig 2). 
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Fig. 2. Effects of barakol (10 mg/kg, i.p.), diazepam (DZP; 1 mg/kg, i.p.), 8-OH-DPAT (DPAT; 0.5 mg/kg, s.c.), 8-OH-
DPAT (0.5 mg/kg, s.c.) + WAY-100635 (WAY; 1 mg/kg, s.c.) and paroxetine (20 mg/kg, i.p.) compared to controls
(CONT; 0.9% saline either i.p. or s.c.) on number of head dipping during 10 min exposed to holeboard test. Data are
expressed as mean + SEM of the number of head dipping. * P< 0.05 compared to subcutaneous injection, # P< 0.05
compared to 8-OH-DPAT injection alone,@ P< 0.05 compared to controls (i.p.) (n = 10 rats/treatment group)  (one way
ANOVA with post hoc Duncan’s test). 
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Time spent head dipping 
Both 8-OH-DPAT (0.5 mg/kg, s.c.) and 
paroxetine (20 mg/kg, i.p.) significantly (p<0.05) 
reduced the time spent head dipping, and the effects 
of  8-OH-DPAT were reversed by WAY-100635 (1 
mg/kg, s.c.) Again, neither DZP (1 mg/kg, i.p.) nor 
barakol (10 mg/kg, i.p.) altered time spent head 
dipping compared to control rats (Fig 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
25
50
75
CONT (i.p.) CONT (s.c.) DPAT WAY+DPAT Paroxetine DZP Barakol
Tim
e o
f h
ea
d d
ipp
ing
@
 *
#
Fig. 3. Effects of barakol (10 mg/kg, i.p.), diazepam (DZP; 1 mg/kg, i.p.), 8-OH-DPAT (DPAT; 0.5 mg/kg, sc.), 8-OH-
DPAT (0.5 mg/kg, sc.) + WAY-100635 (WAY; 1 mg/kg, sc.) and paroxetine (20 mg/kg, i.p.) compared to controls
(CONT; 0.9% saline either i.p. or s.c.) on time of head dipping during 10 min exposed to holeboard test. Data are
expressed as mean + SEM of time of head dipping. * P< 0.05 compared to subcutaneous injection, # P< 0.05 compared
to 8-OH-DPAT injection alone, @ P< 0.05 compared to controls (i.p.) (n = 10 rats/treatment group) (one way ANOVA
with post hoc Duncan’s test). 
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Grooming 
Paroxetine (20 mg/kg, i.p.) significantly 
(P< 0.05) decreased the number of grooms while             
8-OH-DPAT (0.5 mg/kg, s.c.), WAY-100635              
(1 mg/kg, s.c.) prior to 8-OH-DPAT, DZP                       
(1 mg/kg, i.p.) or barakol (10 mg/kg, i.p.) had no 
effect on grooming (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Effects of barakol (10 mg/kg, i.p.), diazepam (DZP; 1 mg/kg, i.p.), 8-OH-DPAT (DPAT; 0.5 mg/kg, s.c.), 8-OH-
DPAT (0.5 mg/kg, s.c.) + WAY-100635 (WAY; 1 mg/kg, s.c.) and paroxetine (20 mg/kg, i.p.) compared to controls
(CONT; 0.9% saline either i.p. or s.c.) on number of grooming during 10 min exposed to holeboard test. Data are
expressed as mean + SEM of the number of grooming. @ P< 0.05 compared to controls (i.p.)  (n = 10 rats/treatment
group) (one way ANOVA with post hoc Duncan’s test). 
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DISCUSSION  
The present study confirms previous 
findings that  8-OH-DPAT (0.5 mg/kg, s.c.), but not 
the benzodiazepine diazepam (1 mg/kg, i.p.) 
significantly decreased exploratory behaviours 
including, rearing, number of head dips and time 
spent head dipping and these effects were 
antagonised by the 5HT1A receptor antagonist, 
WAY 100635 (1 mg/kg, s.c.). Acute paroxetine (20 
mg/kg, i.p.) also inhibited all exploratory activity 
and grooming. In contrast, barakol (10 mg/kg, i.p.) 
like diazepam had no effect on exploratory 
behaviour using the holeboard. 
The present data show that acute 
administration of 8-OH-DPAT (0.5 mg/kg, s.c.) to 
rats clearly inhibited exploration including the 
number of rears per min, the number of head dips 
and time spent head dipping. This result is 
consistent with a previous study8 showing that               
8-OH-DPAT (0.03 - 1 mg/kg, i.p.) but not 
benzodiazepine dose-dependently decreased all of 
the exploratory behaviours in mice observed using a 
holeboard. WAY 100635 (1 mg/kg, s.c.) revered the 
inhibition of exploratory behaviour produced by 8-
OH-DPAT, suggesting that the effects on 
exploration of the holeboard are mediated by 5HT1A 
receptor and not 5HT7 receptor which are also 
activated by 8-OH-DPAT 13. 
Acute administration of paroxetine (20 
mg/kg, i.p.), a 5HT re-uptake inhibitor, significantly 
decreased the number of grooms, rears per min, 
number of head dips and time spent head dipping.  
These results indicate that the mechanism by which 
paroxetine inhibit exploratory behaviour may be 
associated with increased extracellular 5HT 
resulting from 5HT reuptake inhibition causing 
5HT1A receptor activation.  Conversely, it has been 
shown that 14 days after intracerebroventricular 
injection of the neurotoxin 5, 7- dihydroxytryptamine  
(5, 7-DHT), which depletes 5HT there was a significant  
increase exploration in rat on holeboard compared 
to controls14, a finding supported by the present 
study.  However, in a previous study some other 
selective 5HT uptake inhibitors, fluoxetine, 
fluvoxamine and citalopram, had no effect on any 
parameters measured with the holeboard test15.  
A previous study found that chronic 
treatment with DZP (2 mg/kg, oral) throughout 
gestation resulted in reduced holeboard exploration 
in offspring mice (mean age 30.6 days) compared to 
controls16. There is however no evidence that acute 
DZP administration affects exploratory behaviour 
using the holeboard test,8 a finding replicated in the 
present study. 
Surprisingly, barakol produced no change 
in exploratory activity with the holeboard test in 
contrast to previous results using the same dose (10 
mg/kg) with the elevated plus maze2.  The results 
may indicate that barakol does not have effects on 
serotonergic function that can result in a 
behavioural change in exploratory behaviour using 
the holeboard. These results may further indicate 
that alterations in serotonin function are not 
important in the potential anxiolytic properties of 
barakol. 
In summary, the present study 
demonstrated acute treatment of barakol and 
diazepam had no effect on holeboard exploratory 
behaviour while 5HT1A receptor activation reduced 
exploration. Future studies on the effect of barakol 
on holeboard exploration need to be extended using 
a wider dose range of barakol and to investigate 
whether chronic treatment with barakol alters 
exploratory behaviour.  
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